These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 21316721

  • 21. Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants.
    Peréz Aguirreburualde MS, Gómez MC, Ostachuk A, Wolman F, Albanesi G, Pecora A, Odeon A, Ardila F, Escribano JM, Dus Santos MJ, Wigdorovitz A.
    Vet Immunol Immunopathol; 2013 Feb 15; 151(3-4):315-24. PubMed ID: 23291101
    [Abstract] [Full Text] [Related]

  • 22. Comparison of reproductive protection against bovine viral diarrhea virus provided by multivalent viral vaccines containing inactivated fractions of bovine viral diarrhea virus 1 and 2.
    Walz PH, Riddell KP, Newcomer BW, Neill JD, Falkenberg SM, Cortese VS, Scruggs DW, Short TH.
    Vaccine; 2018 Jun 18; 36(26):3853-3860. PubMed ID: 29699786
    [Abstract] [Full Text] [Related]

  • 23. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
    Ficken MD, Ellsworth MA, Tucker CM, Cortese VS.
    J Am Vet Med Assoc; 2006 May 15; 228(10):1559-64. PubMed ID: 16677126
    [Abstract] [Full Text] [Related]

  • 24. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL, Bolin SR, Coe PH, Borges RJ, Coutu CE.
    Am J Vet Res; 2007 Dec 15; 68(12):1417-22. PubMed ID: 18052749
    [Abstract] [Full Text] [Related]

  • 25. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
    Rodning SP, Marley MS, Zhang Y, Eason AB, Nunley CL, Walz PH, Riddell KP, Galik PK, Brodersen BW, Givens MD.
    Theriogenology; 2010 May 15; 73(8):1154-63. PubMed ID: 20181385
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials.
    Makoschey B, Sonnemans D, Bielsa JM, Franken P, Mars M, Santos L, Alvarez M.
    Vaccine; 2007 Aug 10; 25(32):6140-5. PubMed ID: 17336433
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge.
    Fairbanks K, Schnackel J, Chase CC.
    Vet Ther; 2003 Aug 10; 4(1):24-34. PubMed ID: 12756633
    [Abstract] [Full Text] [Related]

  • 28. Antibody responses to inactivated vaccines and natural infection in cattle using bovine viral diarrhoea virus ELISA kits: assessment of potential to differentiate infected and vaccinated animals.
    Raue R, Harmeyer SS, Nanjiani IA.
    Vet J; 2011 Mar 10; 187(3):330-4. PubMed ID: 20074985
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Delayed onset postvaccinal mucosal disease as a result of genetic recombination between genotype 1 and genotype 2 BVDV.
    Ridpath JF, Bolin SR.
    Virology; 1995 Sep 10; 212(1):259-62. PubMed ID: 7676642
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Evaluation of the efficacy of a modified-live combination vaccine against bovine viral diarrhea virus types 1 and 2 challenge exposures in a one-year duration-of-immunity fetal protection study.
    Ficken MD, Ellsworth MA, Tucker CM.
    Vet Ther; 2006 Sep 10; 7(3):283-94. PubMed ID: 17039451
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Electroporation enhances immune responses and protection induced by a bovine viral diarrhea virus DNA vaccine in newborn calves with maternal antibodies.
    van Drunen Littel-van den Hurk S, Lawman Z, Wilson D, Luxembourg A, Ellefsen B, van den Hurk JV, Hannaman D.
    Vaccine; 2010 Sep 07; 28(39):6445-54. PubMed ID: 20670907
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Mucosal immune response in newborn Holstein calves that had maternally derived antibodies and were vaccinated with an intranasal multivalent modified-live virus vaccine.
    Hill KL, Hunsaker BD, Townsend HG, van Drunen Littel-van den Hurk S, Griebel PJ.
    J Am Vet Med Assoc; 2012 May 15; 240(10):1231-40. PubMed ID: 22559114
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.